Viridian Therapeutics, Inc.\DE (VRDN) Other Non Operating Income (2026)
Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Other Non Operating Income came in at $7.5 million in Q1 2026.
Viridian Therapeutics, Inc.\DE (VRDN) Other Non Operating Income (2026) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Other Non Operating Income history runs 1 years deep, the most recent figure standing at $7.5 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,320.50 Bn | 66,320.21 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.93 Bn | 468.14 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.22 Bn | 114.98 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.96 Bn | 61.21 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 56.07 Bn | 50.89 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.60 Bn | 34.59 Bn | 959.66 Mn |
| 10 | Viridian Therapeutics, Inc.\DE | 653.63 Mn | 653.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.53 Mn |